Biokarpet Balance Sheet Health
Financial Health criteria checks 3/6
Biokarpet has a total shareholder equity of €47.0M and total debt of €100.5M, which brings its debt-to-equity ratio to 214%. Its total assets and total liabilities are €208.0M and €161.1M respectively. Biokarpet's EBIT is €9.2M making its interest coverage ratio 1.7. It has cash and short-term investments of €19.0M.
Key information
214.0%
Debt to equity ratio
€100.54m
Debt
| Interest coverage ratio | 1.7x |
| Cash | €19.05m |
| Equity | €46.97m |
| Total liabilities | €161.05m |
| Total assets | €208.03m |
Recent financial health updates
Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of Debt
Oct 10
Is Biokarpet (ATH:BIOKA) Using Too Much Debt?
Oct 21Recent updates
The Return Trends At Biokarpet (ATH:BIOKA) Look Promising
Apr 13Biokarpet's (ATH:BIOKA) Returns On Capital Are Heading Higher
Nov 09Biokarpet (ATH:BIOKA) Seems To Be Using A Lot Of Debt
Oct 10Biokarpet S.A. (ATH:BIOKA) Doing What It Can To Lift Shares
Sep 09Biokarpet (ATH:BIOKA) Might Have The Makings Of A Multi-Bagger
Jul 11Biokarpet (ATH:BIOKA) Is Doing The Right Things To Multiply Its Share Price
Mar 23Do Biokarpet's (ATH:BIOKA) Earnings Warrant Your Attention?
Sep 14Here's Why I Think Biokarpet (ATH:BIOKA) Is An Interesting Stock
Jun 04Investors Will Want Biokarpet's (ATH:BIOKA) Growth In ROCE To Persist
Dec 09Is Biokarpet (ATH:BIOKA) Using Too Much Debt?
Oct 21Biokarpet (ATH:BIOKA) Is Experiencing Growth In Returns On Capital
Jun 03Does Biokarpet (ATH:BIOKA) Have The Makings Of A Multi-Bagger?
Feb 23Financial Position Analysis
Short Term Liabilities: BIOKA's short term assets (€117.6M) exceed its short term liabilities (€60.9M).
Long Term Liabilities: BIOKA's short term assets (€117.6M) exceed its long term liabilities (€100.2M).
Debt to Equity History and Analysis
Debt Level: BIOKA's net debt to equity ratio (173.5%) is considered high.
Reducing Debt: BIOKA's debt to equity ratio has reduced from 251.6% to 214% over the past 5 years.
Debt Coverage: BIOKA's debt is not well covered by operating cash flow (17.3%).
Interest Coverage: BIOKA's interest payments on its debt are not well covered by EBIT (1.7x coverage).